Cesca Therapeutics (KOOL) Misses Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Cesca Therapeutics (KOOL) Receives U.S. Patent Related to Stem Cell Compositions
June 23, 2015 6:04 AM EDTCesca Therapeutics (NASDAQ: KOOL) announced the issuance of U.S. Patent No. 9,050,422 by the U.S. Patent and Trademark Office. The patent for "Stem and Progenitor Cell Compositions Recovered from Bone Marrow or Cord Blood" is a divisional for U.S. Patent No.... More
